Your search returned 4 results.

Results
	1.	Re: "Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder: Design, Definitions, and Ongoing Challenges for Child and Adolescent Psychopharmacology Research" by Strawn JR and Croarkin PE (J Child Adolesc Psychopharmacol 2018;28:(5)363). [electronic resource] by Weihs, Karen L Wajsbrot, Dalia B Chiles, Deborah Ramaker, Sara Chappell, Phil Producer: 20200630 In: Journal of child and adolescent psychopharmacology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Safety and tolerability of desvenlafaxine in children and adolescents with major depressive disorder. [electronic resource] by Findling, Robert L Groark, James Chiles, Deborah Ramaker, Sara Yang, Lingfeng Tourian, Karen A Producer: 20150112 In: Journal of child and adolescent psychopharmacology vol. 24 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder. [electronic resource] by Weihs, Karen L Murphy, William Abbas, Richat Chiles, Deborah England, Richard D Ramaker, Sara Wajsbrot, Dalia B Producer: 20190416 In: Journal of child and adolescent psychopharmacology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Pharmacokinetics and Tolerability of Single-Ascending Doses of Desvenlafaxine Administered to Children and Adolescents with Major Depressive Disorder. [electronic resource] by Findling, Robert L Groark, James Tourian, Karen A Ramaker, Sara A Chiles, Deborah Yang, Lingfeng Nichols, Alice I Producer: 20171213 In: Journal of child and adolescent psychopharmacology vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)